Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

August 12, 2018

Correspondence response
Response to: ‘Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated’ by Moiseev et al

Liang Wu, Min Chen

doi: 10.1136/annrheumdis-2018-214145
Correspondence response
Response to: ‘Checkpoint inhibitors and arthritis: seeking balance between victories and defeats’ by Moura and Moura

Thierry Schaeverbeke, Marie Kostine

doi: 10.1136/annrheumdis-2018-213906

August 10, 2018

Correspondence response
Response to: ’Early identification of rheumatoid arthritis; the risk of overtreatment in perspective' by Landewé

Robert B M Landewé

doi: 10.1136/annrheumdis-2018-214172
Correspondence
Early identification of rheumatoid arthritis: the risk of overtreatment in perspective

Annette van der Helm-van Mil

doi: 10.1136/annrheumdis-2018-214156

July 30, 2018

Correspondence
Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated

Nikolai Bulanov, Natalia V Chebotareva, Pavel I Novikov, Sergey V Moiseev

doi: 10.1136/annrheumdis-2018-214095
Correspondence
Response to viewpoint ‘Defining refractory rheumatoid arthritis’ by Buch

Nadia MT Roodenrijs, Maria JH de Hair, Marlies C van der Goes, Johannes WG Jacobs

doi: 10.1136/annrheumdis-2018-214147

July 27, 2018

Correspondence response
Response to: ‘Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors’ by Delyon et al

Marie Kostine, Thierry Schaeverbeke on behalf of the FHU-ACRONIM

doi: 10.1136/annrheumdis-2018-213895

July 21, 2018

Correspondence response
Response to: ‘Can we further SPARkle the SPAR model?’ by Kavadichanda et al

Wanlong Wu, Suzana Jordan, Oliver Distler

doi: 10.1136/annrheumdis-2018-213962

July 20, 2018

Correspondence
Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?

Gaetane Nocturne, Raphaele Seror, Xavier Mariette

doi: 10.1136/annrheumdis-2018-213979
Correspondence response
Response to: ‘Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?’ by Nocturne et al

Efstathia K Kapsogeorgou, Aristea Papageorgiou, Athanase D Protogerou, Michael Voulgarelis, Athanasios G Tzioufas

doi: 10.1136/annrheumdis-2018-214009

July 12, 2018

Correspondence response
Response to: ‘The use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?’ by Wu et al

Lennart Jans, Isabelle De Kock, Nele Herregods, Koenraad L Verstraete, Filip E Van den Bosch, Philippe Carron, Edwin H Oei, Dirk Elewaut, Peggy Jacques

doi: 10.1136/annrheumdis-2018-213960
Correspondence
Use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?

Haijun Wu, Guangfeng Zhang, Xiaoyu Huang, Changhong Liang

doi: 10.1136/annrheumdis-2018-213892

July 10, 2018

Correspondence response
Response to: ‘Inconsistency between supplement and article?’ by Babaoglu H

Désirée van der Heijde, Natasha de Peyrecave, Tommi Nurminen

doi: 10.1136/annrheumdis-2018-213887

June 29, 2018

Correspondence
Variation in antinuclear antibody detection: need for clear expectations and additional studies

Michael Mahler, Carolina Auza

doi: 10.1136/annrheumdis-2018-213888
Correspondence
Can we further SPARkle the SPAR model?

Chengappa G Kavadichanda, Vir Singh Negi

doi: 10.1136/annrheumdis-2018-213954

June 27, 2018

Correspondence response
Response to: ‘Infrapatellar fat pad resection during total knee replacement: yet another reason?’ by Ryan

Zhaohua Zhu, Weiyu Han, Guangfeng Ruan, Shuang Zheng, Changhai Ding

doi: 10.1136/annrheumdis-2018-213701
Correspondence
Checkpoint inhibitors and arthritis: seeking balance between victories and defeats

Carlos Antonio Moura, Carlos Geraldo Moura

doi: 10.1136/annrheumdis-2018-213866

June 26, 2018

Correspondence
Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus

Fan Wang, Wei Zhang, Shiying Wang, Wenyou Pan, Lin Liu, Min Wu, Fuwan Ding, Huaixia Hu, Xiang Ding, Hua Wei, Yaohong Zou, Xian Qian, Meimei Wang, Jian Wu, Juan Tao, Jun Tan, Zhanyun Da, Miaojia Zhang, Jing Li, Xuebing Feng, Lingyun Sun

doi: 10.1136/annrheumdis-2018-213819
Correspondence response
Response to: ’Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus' by Wang et al

Nadine Müller-Calleja, Karl J Lackner

doi: 10.1136/annrheumdis-2018-213853

June 23, 2018

Correspondence response
Response to: ‘Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities’ by Bossuyt et al

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2018-213841
Correspondence
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors

Anissa Roger, Matthieu Groh, Gwenael Lorillon, Claire Le Pendu, Jeremy Maillet, Dimitri Arangalage, Abdellatif Tazi, Celeste Lebbe, Barouyr Baroudjian, Julie Delyon the PATIO group

doi: 10.1136/annrheumdis-2018-213857
Correspondence
Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities

Philippe Willems, Ellen De Langhe, René Westhovens, Steven Vanderschueren, Daniel Blockmans, Xavier Bossuyt

doi: 10.1136/annrheumdis-2018-213821

June 22, 2018

Correspondence response
Response to: ‘Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1’ by Michot et al

Marie Kostine, Christophe Richez, Thierry Schaeverbeke on behalf of the FHU- ACRONIM

doi: 10.1136/annrheumdis-2018-213691

June 20, 2018

Correspondence response
Response to: ’Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass

Marie Kostine, Léa Dousset, Thierry Schaeverbeke on behalf of the FHU-ACRONIM

doi: 10.1136/annrheumdis-2018-213682
Correspondence
Treatment of hip osteoarthritis with glucocorticoids

Jian Zhou, Biao Liu, Chenxi Li, Yingquan Luo, Tang Liu, Wanchun Wang

doi: 10.1136/annrheumdis-2018-213871

June 19, 2018

Correspondence
Inconsistency between supplement and article?

Hakan Babaoglu

doi: 10.1136/annrheumdis-2018-213844
Correspondence
Rituximab in ANCA-associated vasculitis: fewer infusions or ultra low-dose maintenance therapy?

Sergey V Moiseev, Nikolai M Bulanov, Anastasiia S Zykova, Pavel I Novikov

doi: 10.1136/annrheumdis-2018-213873

June 16, 2018

Correspondence response
Response to: ‘Association between use of non-steroidal anti-inflammatory drugs and risk of myocardial infarction in patients with spondyloarthritis and osteoarthritis’

Maureen Dubreuil, Qiong Louie-Gao, Christine Peloquin, Hyon K Choi, Yuqing Zhang, Tuhina Neogi

doi: 10.1136/annrheumdis-2018-213771

June 06, 2018

Correspondence response
Response to: ‘Serum complement factor C5a in IgG4-related disease’ by Fukui et al

Hisanori Umehara, Mitsuhiro Kawano

doi: 10.1136/annrheumdis-2018-213729
Correspondence
Serum complement factor C5a in IgG₄-related disease

Shoichi Fukui, Yuya Fujita, Tomoki Origuchi, Takahiro Maeda, Atsushi Kawakami

doi: 10.1136/annrheumdis-2018-213705

June 01, 2018

Correspondence
Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1

Jean-Marie Michot, Mathilde Fusellier, Stephane Champiat, Charles Velter, Capucine Baldini, Anne-Laure Voisin, Francois-Xavier Danlos, Yolla El Dakdouki, Maxime Annereau, Xavier Mariette, Caroline Robert, Khadija Cherif, Aurélien Marabelle, Christine Mateus, Olivier Lambotte

doi: 10.1136/annrheumdis-2018-213677
Correspondence response
Response to: ’Not all drugs (and routes) are same' by Zanwar and Gandhi

Pierre Charles, Loic Guillevin

doi: 10.1136/annrheumdis-2018-213742
Correspondence
Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou et al: mutations in TRNT1 result in a constitutive activation of type I interferon signalling

Marie-Louise Frémond, Isabelle Melki, Sven Kracker, Vincent Bondet, Darragh Duffy, Gillian I Rice, Yanick J Crow, Brigitte Bader-Meunier

doi: 10.1136/annrheumdis-2018-213745
Correspondence
‘Not all drugs (and route) are same’

Abhishek Arvind Zanwar

doi: 10.1136/annrheumdis-2018-213730

May 31, 2018

Correspondence
Are the loading dose treatment groups superior to the 150 mg without loading dose group in the secukinumab FUTURE 5 study?

Bernardo Matos da Cunha

doi: 10.1136/annrheumdis-2018-213770
Correspondence response
Response to ‘A missing pebble in the mosaic of rheumatic diseases and mental health: younger does not always mean happier’ by Alunno et al

Imke Redeker, Falk Hoffmann, Johanna Callhoff, Hildrun Haibel, Joachim Sieper, Angela Zink, Denis Poddubnyy

doi: 10.1136/annrheumdis-2018-213620
Correspondence
Multimodal analgesia to reduce NSAID induced myocardial Infarction

Leigh White, Gun Hee An, Ruan Vlok

doi: 10.1136/annrheumdis-2018-213732
Correspondence
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: time to focus on

Pietro Enea Lazzerini, Franco Laghi Pasini, Maurizio Acampa, Pier Leopoldo Capecchi

doi: 10.1136/annrheumdis-2018-213789

May 25, 2018

Correspondence
Association between use of non-steroidal anti-inflammatory drugs and risk of myocardial infarction in patients with spondyloarthritis and osteoarthritis

Jian Zhou, Ying Xiao, Chenxi Li, Tang Liu, Wanchun Wang

doi: 10.1136/annrheumdis-2018-213752

May 18, 2018

Correspondence response
Response to: ’To DAPSA or not to DAPSA? That is not the question' by Schoels et al

Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, Dominique L P Baeten, Laura C Coates

doi: 10.1136/annrheumdis-2018-213618

May 15, 2018

Correspondence
Infrapatellar fat pad resection during total knee arthroplasty: yet another reason for?

Thomas J Ryan

doi: 10.1136/annrheumdis-2018-213684

May 14, 2018

Correspondence
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor

Karmela Kim Chan, Anne R Bass

doi: 10.1136/annrheumdis-2018-213672

May 05, 2018

Correspondence response
Response to: ‘Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: the positive experience of a national multi-center study’ by Pregnalato et al

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2018-213582
Correspondence
To DAPSA or not to DAPSA? That is not the question

Monika M Schoels, Josef S Smolen, Daniel Aletaha

doi: 10.1136/annrheumdis-2018-213548
Correspondence response
Response to: ‘Variation in antinuclear antibody detection by automated indirect immunofluorescence analysis’ by van Hoovels et al

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2018-213558

May 03, 2018

Correspondence
Tofacitinib in steroid-dependent relapsing polychondritis

Alexey D Meshkov, Pavel I Novikov, Evgeny V Zhilyaev, Ilia David J Ilevsky, Sergey V Moiseev

doi: 10.1136/annrheumdis-2018-213554
Correspondence
Checkpoint inhibitor-associated immune arthritis

Laurent Arnaud, Bénédicte Lebrun-Vignes, Joe-Elie Salem

doi: 10.1136/annrheumdis-2018-213470
Correspondence response
Response to: ‘Time to personalise the treatment of anti-MDA-5 associated lung disease’ by Lake et al

Valérie Leclair, Ingrid E Lundberg, Anna Tjärnlund

doi: 10.1136/annrheumdis-2018-213519

April 28, 2018

Correspondence
Missing pebble in the mosaic of rheumatic diseases and mental health: younger does not always mean happier

Alessia Alunno, Paul Studenic, Dieter Wiek, Petra Balážová, Daniel Aletaha

doi: 10.1136/annrheumdis-2018-213611
Correspondence response
Response to: ’Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?' by Meroni et al

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2018-213537

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

August 12, 2018

August 10, 2018

July 30, 2018

July 27, 2018

July 21, 2018

July 20, 2018

July 12, 2018

July 10, 2018

June 29, 2018

June 27, 2018

June 26, 2018

June 23, 2018

June 22, 2018

June 20, 2018

June 19, 2018

June 16, 2018

June 06, 2018

June 01, 2018

May 31, 2018

May 25, 2018

May 18, 2018

May 15, 2018

May 14, 2018

May 05, 2018

May 03, 2018

April 28, 2018

Pages